- Home
- OCS
as 12-17-2024 4:00pm EST
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
| Founded: | 2003 | Country: | Switzerland |
| Employees: | N/A | City: | N/A |
| Market Cap: | 717.3M | IPO Year: | N/A |
| Target Price: | $29.20 | AVG Volume (30 days): | 39.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.12 | EPS Growth: | N/A |
| 52 Week Low/High: | $10.11 - $18.00 | Next Earning Date: | 11-07-2024 |
| Revenue: | $1,027,571 | Revenue Growth: | -4.82% |
| Revenue Growth (this year): | 6.87% | Revenue Growth (next year): | 884.16% |
Latest Oculis Holding AG Ordinary shares News
OCS Breaking Stock News: Dive into OCS Ticker-Specific Updates for Smart Investing
GlobeNewswire
12 days ago
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
GlobeNewswire
19 days ago
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated
GlobeNewswire
21 days ago
Oculis Publishes Notification of Transaction by Person Discharging Managerial Responsibilities
GlobeNewswire
a month ago
Oculis to Present at the Stifel 2024 Healthcare Conference
GlobeNewswire
a month ago
Oculis to Present at the Stifel 2024 Healthcare Conference
Simply Wall St.
a month ago
Oculis Holding Third Quarter 2024 Earnings: Misses Expectations
GlobeNewswire
a month ago
Oculis Reports Q3 2024 Financial Results and Provides Company Updates
Simply Wall St.
2 months ago
Oculis Holding AG's (NASDAQ:OCS) largest shareholders are individual investors with 56% ownership, institutions own 39%
Compare OCS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OCS Oculis Holding AG Ordinary shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.